| Views | |
|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 141 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology | 7 | 12 | 18 | 36 | 10 | 14 | 11 |
| Views | |
|---|---|
| 2022_Scheibe_etal.pdf | 64 |
